Inhibition of γ-synuclein (SNCG) expression in breast cancer MDA-MB231 cell line
Tao Ren(First Affiliated Hospital of Chengdu Medical College), Yeqin Zhou(North Sichuan Medical University), Bangxian Tan(Affiliated Hospital of North Sichuan Medical College), Daiyuan Ma, Yan Gui(First Hospital of Lanzhou University), Xiaojie Ma(North Sichuan Medical University)
Cited by 0
Related Papers
Randomized Trial of First-Line Tyrosine Kinase Inhibitor With or Without Radiotherapy for Synchronous Oligometastatic <i>EGFR</i>-Mutated Non-Small Cell Lung Cancer
|JNCI Journal of the National Cancer Institute|2022|267
Treatment outcomes after reduction of the target volume of intensity-modulated radiotherapy following induction chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: A prospective, multi-center, randomized clinical trial
|Radiotherapy and Oncology|2017|104
Research progress on the mechanism of radiation enteritis
|Frontiers in Oncology|2022|42
Concurrent three-dimensional conformal radiotherapy and chemotherapy for postoperative recurrence of mediastinal lymph node metastases in patients with esophageal squamous cell carcinoma: a phase 2 single-institution study
|Radiation Oncology|2014|41
Reducing Target Volumes of Intensity Modulated Radiation Therapy After Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: Long-Term Results of a Prospective, Multicenter, Randomized Trial
|International Journal of Radiation Oncology*Biology*Physics|2023|34